Initial Clinical Experience with Clinafloxacin in the Treatment of Serious Infections
Miscellaneous Clinical Studies
- 7 Downloads
KeywordsCystic Fibrosis Cystic Fibrosis Patient Bronchiectasis Sparfloxacin Fleroxacin
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- 1.Fuchs PC, Barry AL, Pfaller MA, et al. Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates. Antimicrob Agents Chemother 1991; 35 (4): 764–6PubMedCrossRefGoogle Scholar
- 2.Jones RN, Johnson DM. Modification for disk diffusion susceptibility testing criteria of CLF (CI-960, AM-1091, CP127371) and fleroxacin (RO 23-6240, AM-833) following studies with a challenge-panel of ciprofloxacin-resistant clinical isolates. Diagn Microbiol Infect Dis. In pressGoogle Scholar
© Adis International Limited 1995